FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1319111000001107: Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21485101000001119 Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60496301000001113 Ethinylestradiol 35microgram / Norgestimate 250microgram tablets 63 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Is pack of Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has VMP Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has specific active ingredient Norgestimate true Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 63 tablet 3 x 21 tablets Is a True Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Is a True Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Cilest 250microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) 63 tablet Is a True Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Is a True Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (A A H Pharmaceuticals Ltd) 63 tablet 3 x 21 tablets Is a False Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (AM Distributions (Yorkshire) Ltd) 63 tablet 3 x 21 tablets Is a False Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd) 63 tablet 3 x 21 tablets Is a True Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) 63 tablet Is a False Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Colorama Pharmaceuticals Ltd) 63 tablet 3 x 21 tablets Is a False Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start